Home › NDC Lookup › Ingredients › Salicylic Acid 2% › 87013-0004-01
Swiftalyn Antifungal Scalp Shampoo. Salicylic Acid 2% 20 mg/g Shampoo, 280 g — NDC 87013-0004-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Swiftalyn Antifungal Scalp Shampoo. Salicylic Acid 2% 20 mg/g Shampoo, 280 g — NDC 87013-004-01 (Billing 87013-0004-01)

by GENUINE INNOVATION LTD · 280 g in 1 BOTTLE

This is a package of 280 g of Swiftalyn Antifungal Scalp Shampoo. Salicylic Acid 2% 20 mg/g Shampoo from GENUINE INNOVATION LTD, marketed since May 2026 and currently FDA-listed. It is this product's only package size.

NDC 87013-0004-01
🏷️ FDA NDC (as labeled) 87013-004-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 87013-004-01
Product NDC 87013-004
11-digit billing NDC 87013000401
RxCUI 205104
UNII O414PZ4LPZ
Application # M032
SPL Set ID 53f84e9f-ecc1-dfc2-e063-6394a90af243
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-05-20
Route TOPICAL
Dosage form SHAMPOO
Substance SALICYLIC ACID
Quick answers
  • RxCUI (RxNorm): 205104
Why two NDCs? The FDA registers this code as 87013-004-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87013-0004-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Salicylic acid and derivatives class.

Drug family (ATC) Salicylic acid and derivatives, Other antifungals for topical use, Antiinflammatory agents, non-steroids
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It is used in a facial routine for acne-prone and oil-prone skin. The routine includes a cleanser, serum, toner and emulsion. Salicylic acid helps loosen and shed dead skin cells.
  • Use the cleanser morning and evening, and the serum in the morning after cleansing. Use the toner in the evening on dry skin, and the emulsion at night after cleansing. Avoid your...
  • Mild stinging, burning, itching, dryness and extra peeling can happen. If dryness or peeling bothers you, try using the serum or toner every other day. If it gets excessive, stop a...
  • It is best not to. Using another topical acne medication at the same time makes irritation and dryness more likely. If you get irritated, use only one at a time.
📖 Read our full Salicylic Acid Topical guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
87013-0004-01 You're viewing this Main listing 280 g in 1 BOTTLE 2026-05-20 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Satinique Anti Dandruff Scalp and Hair 20 mg/mL 10056-0536-00 Access 280 ml — — FDA listed —
Sulfur 8 Medicated Dandruff with Salicylic Acid 20 mg/mL 12022-0039-00 J. 222 ml — — FDA listed —
Glovers Therapeutic Care 20 mg/mL 12022-0040-00 J. 118 ml — — FDA listed —
Texture ID Anti Dandruff Peppermint Oil and Aloe .02 g/g 60717-0410-12 RNA 1 g — — FDA listed —
Texture ID Anti Dandruff Peppermint Oil and Aloe Conditioner .02 g/g 60717-0411-12 RNA 1 g — — FDA listed —
RE-fresh Scalp Care 2 g/100mL 64942-1928-01 Conopco, 400 ml — — FDA listed —
RE-fresh Scalp Care 2 g/100mL 64942-1929-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-1964-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-1966-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-1968-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-1970-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-1972-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-2058-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-2059-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-2060-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-2061-01 Conopco, 400 ml — — FDA listed —
bhs beautiful hair and scalp 2 g/100mL 64942-2062-01 Conopco, 400 ml — — FDA listed —
Mens Rogaine 2% Salicylic Acid Anti-Dandruff Plus Conditioner 20 mg/mL 69968-0954-02 Kenvue 248 ml — — FDA listed —
Oribe Serene Scalp Anti Dandruff 2 g/100g 71438-0010-07 Oribe 1 packet — — FDA listed —
Oribe Serene Scalp Anti Dandruff 2 g/100g 71438-0020-12 Oribe 1 tube — — FDA listed —
Pert 2 in 1 Advanced plus 2 g/100mL 81277-0802-13 Sodalis 400 ml — — FDA listed —
Hermon Folliculitis Shampoo. 8 g/400mL 85398-0009-01 Beautivity 400 ml — — FDA listed —
ProBliva Anti Fungal Shampoo. 4.72 g/236g 85464-0003-01 CAVTECH 236 g — — FDA listed —
Swiftalyn Antifungal Scalp Shampoo. 20 mg/gthis 87013-0004-01 GENUINE 280 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
May 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGENUINE INNOVATION LTD
FDA applicationM032 (OTC MONOGRAPH DRUG)
Labeler code87013
First marketedMay 2026
Product typeHuman Otc Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 23 words ▾

Controls, fights, and helps prevent recurrence of the symptoms of dandruff, seborrheic dermatitis, and psoriasis, including scalp itching, irritation, redness, flaking, and scaling.

⏱️ Dosage and Administration 34 words ▾

Wet hair thoroughly. Apply shampoo and gently massage into the scalp. Leave on for a few minutes. Rinse thoroughly. For best results use at least twice a week or as directed by a doctor.

⚠️ Warnings 61 words ▾

For external use only. Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water. Condition worsens or does not improve after regular use of this product as directed. If the condition covers a large area of the body, consult your doctor before using this product. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 3 words ▾

Salicylic Acid 2%

🧪 Inactive Ingredients 69 words ▾

Aqua, Butylene Glycol, Sodium Cocoyl Amino Acids, Sodium Methyltaurate, Sodium Sarcosinate, Cocos Nucifera (Coconut) Oil, Sodium Cocoyl Glycinate, Sodium Lauroyl Glutamate, Sodium Chloride, Hydrolyzed Rice Extract, Tea Tree Oil, Piroctone Olamine, Caffeine, Biotin, Hydrolyzed Keratin, Zingiber Officinale (Ginger) Root Oil, Citrus Reticulata (Tangerine) Peel Extract, Rosmarinus Officinalis (Rosemary) Leaf Oil, Glycyrrhiza Glabra (Licorice) Root Extract, Centella Asiatica Extract, Guar Hydroxypropyltrimonium Chloride, Dimethicone, Phenoxyethanol, Ethylhexylglycerin, Polyquaternium-10, Citric Acid, Sodium Citrate.

🎯 Purpose 4 words ▾

Antidandruff, Seborrheic dermatitis, Psoriasis

📄 When Using This Product 13 words ▾

Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

📄 Stop Use and Ask a Doctor If 31 words ▾

Condition worsens or does not improve after regular use of this product as directed. If the condition covers a large area of the body, consult your doctor before using this product.

📄 Keep Out of Reach of Children 13 words ▾

If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 10 words ▾

Store in a cool, dry place, away from direct sunlight.

📄 Questions or Comments 2 words ▾

Email: [email protected]

📄 Package Label / Principal Display Panel 2 words ▾

Swiftalyn Shampoo

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Swiftalyn Antifungal Scalp Shampoo. (this brand).

Top reported reactions

Erythema1
Middle Insomnia1
Skin Discolouration1
Thermal Burn1

Reporter sex

1 reports
Male · 100%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by GENUINE INNOVATION LTD. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
GENUINE INNOVATION LTD is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 87013-0003-01 · GENUINE 87014-0001-01 · REGENEREN →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.